MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHA, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHA, S.

Molecular Pharmacology, Vol 4, 621-629, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics

Kinetics of Enzyme Reactions with Competing Alternative Substrates

SUNGMAN CHA 1

1 Division of Biological and Medical Sciences, Brown University, Providence, Rhode Island 02912

When two alternative substrates are present simultaneously in an enzyme reaction, and one is a better substrate (higher Vmax) than the other, the combined rate of the two reactions may be greater than, equal to, or less than the rate observed with the better substrate alone. At some concentration of the better substrate, the poorer substrate will appear to have no effect. On a plot of the combined velocity against the concentration of the more effective substrate, the family of curves obtained, each representing a different level of the poorer substrate, will have a common point of intersection. This phenomenon can be exploited effectively to determine whether or not a single enzyme catalyzes two similar reactions, or to determine whether or not two drugs act on the same receptor.

In examining the applicability of these conclusions to more complex enzyme mechanisms, six variations of two major bi-bi (two-substrate, two-product) mechanisms have been studied. It was found that in every case, the formal theory based on the simple Michaelis-Menten mechanism holds, provided that apparent Michaelis constants are used.

Submitted on July 22, 1968




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
T. A. Clarke and L. A. Waskell
The Metabolism of Clopidogrel Is Catalyzed by Human Cytochrome P450 3A and Is Inhibited by Atorvastatin
Drug Metab. Dispos., January 1, 2003; 31(1): 53 - 59.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
P. Carroll and J. Aspry
Subcellular origin of cholinergic transmitter release from mouse brain
Science, November 7, 1980; 210(4470): 641 - 642.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics